Clinical Trial Update: Furosemide Treatment Before Blood Transfusion in Patients With Systolic Dysfunction [NA]

View source ↗

Summary

The clinical trial examining furosemide before blood transfusion in patients with left ventricular systolic dysfunction has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Left Ventricular Systolic Dysfunction

Drugs mentioned

• FUROSEMIDE (Furosemide)

Snippet

Sponsor: Tel-Aviv Sourasky Medical Center | Conditions: Anemia Treatment Among Patients Suffering From Left Ventricular Systolic Dysfunction | NA | Status: WITHDRAWN